There are distinct racial disparities in cardiovascular disease (CVD) risk, with Black individuals at much greater risk than White individuals. Although many factors contribute to these disparities, recent attention has focused on the role of discrimination as a stress-related factor that contributes to racial disparities in CVD. As such, it is important to understand the mechanisms by which discrimination might affect CVD. Recent studies have examined these mechanisms by focusing on neurobiological mediators of CVD risk. Given this increase in studies, a systematic review of perceived discrimination and neurobiological mediators of CVD risk is warranted. Our review uses a multisystem approach to review studies on the relationship between perceived discrimination and (1) cardiovascular responses to stress, (2) hypothalamic-pituitary-adrenocortical axis function, and (3) the immune system, as well as (4) the brain systems thought to regulate these parameters of peripheral physiology. In addition to summarizing existing evidence, our review integrates these findings into a conceptual model describing multidirectional pathways linking perceived discrimination with a CVD risk.
Introduction
Cardiovascular disease (CVD) is the leading cause of death in the United States and other developed nations. There are stark racial disparities in CVD, with Black individuals at much greater risk than White individuals. 1 Multiple factors contribute to these disparities, including differences in environmental exposures, health care, and health behaviors. Recent attention has also focused on the possibility that chronic and differential exposure to stressors contribute to racial disparities in CVD. In this regard, Black individuals in the United States report experiencing higher levels of racial discrimination compared with White individuals. 2 Higher levels of discrimination are associated with poorer mental and physical health, including a greater risk for CVD. 3, 4 This evidence supports the possibility that discrimination is a stress-related process that contributes to racial disparities in CVD. As such, it is important to understand the mechanisms by which discrimination might affect CVD. Recent studies have examined these mechanisms by focusing on neurobiological mediators of CVD risk. Here, neurobiological mediators refer to interacting central and peripheral nervous system determinants of risk for CVD (e.g., neural mechanisms that regulate cardiovascular physiology, systemic inflammation, etc.). Examining the relationship between perceived discrimination and these mediating determinants of clinical CVD might tell us more about possibly modifiable biological processes than focusing exclusively on late-stage clinical outcomes, where windows of prevention and intervention begin to close. Currently, a systematic review of perceived discrimination and neurobiological mediators of CVD risk is not available. Our review focuses on cardiovascular responses to stress, hypothalamic-pituitary-adrenocortical (HPA) axis function, and the immune system, as well as the doi: 10.1111/nyas.13939 brain systems thought to regulate these parameters of peripheral physiology. Prior to the review of neurobiological mediators, we describe racial disparities in CVD and guiding definitions of discrimination in the context of race. We then give a brief summary of prior reviews of the literature on discrimination and health before closing with a working neurobiological model of discrimination and cardiovascular health disparities.
Racial disparities in CVD
CVD is a leading cause of early mortality among adults. Although rates of CVD have been in decline for many decades, owing to advances in treatment and public health campaigns, not all people have benefited equally from these advances. In particular, the current CVD prevalence and death rates among Black adults are still substantially higher than White adults. 5 At present, for example, prevalence rates of CVD are substantially higher among Black males (46%) and females (46%) than among White males (38%) and females (32%). 5 Hypertension prevalence, in particular, differs markedly between Black (43%) and White (29%) adults. 6 Beyond prevalence, current CVD-related death rates are higher among Black individuals compared with their White counterparts. 5 Moreover, Black-White disparities in CVD mortality rates appear to have widened in recent years. 7 Notably, and by comparison, CVD prevalence and death rates among Latino and Asian participants are similar to or less than White participants. 8, 9 As such, understanding the factors that contribute to Black-White CVD disparities is a public health priority. At the level of public health, it is thought that racial disparities may be attributed in part to structural and institutional barriers, such as access to quality food, healthcare, safe environments, and educational opportunities. Stress-related psychosocial factors have also long been thought to play a role. In the latter regard, discrimination may be one such psychosocial factor, as Black individuals report significantly more racial discrimination than White individuals. 2, 10, 11 Defining and measuring discrimination To discriminate against someone is to treat that person unfairly based on the group with which that person identifies; groups could be based on categories such as race, age, or sex. 12, 13 Discrimination itself is a multidimensional construct that can arise from many kinds of events and actions, ranging from acute interpersonal events or actions to institutional policies that systematically disenfranchise, exclude, or otherwise treat certain groups unfavorably. Discrimination varies both by time scale (e.g., acute and chronic) and domain (e.g., interpersonal, internalized, and institutional).
In discussing discrimination, it is essential to consider the historical and cultural context in which it can occur. For example, although individuals from many groups report discriminatory experiences, discrimination is disproportionately experienced by individuals who belong to groups that have been historically disenfranchised, oppressed, and marginalized. 12, 14 This historical and cultural context creates systematic and institutional inequality on many levels. One implication of this inequality is that those who experience the most discrimination are more likely to have disadvantaged social status, greater exposure to other environmental and personal stressors, and reduced access to material and social resources that could be used to effectively respond to or cope with discrimination. [14] [15] [16] [17] Moreover, discrimination itself can act as a barrier, limiting actual and perceived access to resources, such as quality healthcare and education. 14, 16 Despite the historical and structural nature of discrimination, it is difficult to measure its facets on an individual level. As such, studies in our review focus primarily on perceived interpersonal discrimination. There are two main reasons for this: first, self-reports of perceived discrimination are the most commonly used discrimination measures in the psychology and epidemiological literatures. Second, perceived discrimination measures aim to capture an individual's appraisal of discriminatory treatment; this appraisal process determines whether the treatment is evaluated as stressful, or as a threat that taxes or exceeds an individual's available coping resources. 18 As such, perceived discrimination is widely considered to be a psychosocial stressor for the targeted individual. 19 Several facets of perceived discrimination make it a complex and unique stressor. First, the historical context of discrimination discussed earlier in our review contributes appreciably to its complexity, entrenchment, and singularity. Second, perceived discrimination typically involves some degree of social exclusion or rejection of the target and/or the target's group. Social exclusion has a number of negative implications for the individual, as it threatens basic needs for acceptance and inclusion. [20] [21] [22] Third, perceived discrimination requires targets to manage the emotional and practical consequences of discrimination-not only for themselves as individuals, but also as members of their social group. Threats toward or social rejection of one's group can damage an individual's self-concept and social identity. 23 Fourth, perceived discrimination often involves unfair treatment based on characteristics of the self that the individual has not chosen (e.g., race and sex) by the individual; discrimination is a stressor that is not caused by the targeted individual. For this reason, perceived discrimination often evokes feelings of powerlessness or lack of control, as well as anger and hostility. 24 Fifth, perceived discrimination typically has both short-and long-term implications for the target, in that the individual has to manage both the immediate stress of an incident and any lasting effects of the experience (e.g., rumination or concern about the status of one's social group). 15, 16, 25 For this reason, perceived discrimination can be considered both an acute and chronic stressor. Relatedly, perceived discrimination may have a particularly significant impact on the individual through stress proliferation, or the process by which exposure to a major stressor can generate or increase the odds of exposure to other stressors. 16, 26, 27 Taken together, these aspects of perceived discrimination make it a particularly complex and difficult psychosocial stressor. As such, detailed examination of its impacts on health is warranted.
In our review, we will focus primarily on individuals' self-reports of perceived discrimination. Perceived discrimination questionnaire measures draw on experiences of interpersonal or individual-level discrimination; such measures vary in a timescale, with some measuring acute events and others assessing chronic exposure. These measures typically ask participants about past personal experiences with discriminatory or unfair treatment; many also ask about the extent to which participants believe the treatment was due to their race or other facet of their identity. One of the most common measures of perceived discrimination is the Everyday Discrimination Scale, which asks participants how often they experience different types of unfair treatment on a day-to-day basis and what they think the main reason is for that treatment (e.g., race, gender, age, etc.). 28 For example, one item from this scale asks participants "In your day-to-day life, how often are you treated with less respect than other people are?" Other conventional measures of perceived discrimination aim to capture chronic discrimination by asking participants to report on their lifetime history of perceived discrimination. For example, the Racism and Life Experiences Scale asks participants "How much have you personally experienced racism, racial discrimination, or racial prejudice during your lifetime in your employment/job?" 29 Most measures of perceived discrimination in our review are specific to racial or ethnic discrimination. However, some focus more generally on unfair treatment that may or may not be attributable to race or ethnicity. Such treatment may also be attributable to other identities (e.g., gender and age). In our review, we refer to nonspecific measures as general discrimination and to race-or ethnicity-specific measures as racial discrimination. While elements of the emotional experience of perceived discrimination may be shared across identities, racial discrimination may be more pertinent to racial health disparities. Studies that assess general discrimination will be noted and discussed when relevant.
In addition to questionnaire measures, some studies in our review simulate discrimination in the laboratory. Such simulations are modeled after laboratory studies of acute stress, allowing researchers to measure physiological responses presumed to confer disease risk in a controlled setting. Such studies use heterogeneous methods, which are discussed in detail below.
Race differences in perceived discrimination
Individuals across races and ethnicities report experiences of racial discrimination. Black participants consistently report the most frequent or severe racial discrimination, White participants tend to report the least, and other racial/ethnic groups often fall somewhere in between Black and White groups. 2, 10, 11 Latino and Asian participants typically report less discrimination compared with Black participants, but vary across studies when compared with White participants. 10, [30] [31] [32] Variations in perceived discrimination within racial groups may be due to crude divisions of these groups; in reality, these groups are highly heterogeneous in national origin, language, culture, and several other factors that may affect discriminatory treatment. Considering this caveat, the literature as a whole indicates that Black individuals report the highest levels of racial discrimination and White individuals typically report the lowest.
Perceived discrimination and health
Greater perceived discrimination is associated with poorer mental 4, 25, 33, 34 and physical health. 4, 12, 33 With regard to mental health, perceived discrimination is associated with greater psychological distress and reduced psychological well-being. 25, 34 This association is evident across a range of psychological outcomes, including distress, depressive symptoms, anxiety, self-esteem, and other psychiatric symptoms. 25, 33, 34 Notably, associations between perceived racial discrimination and mental health are often strongest among racial and ethnic minorities compared with White participants. 25, [33] [34] [35] With regard to physical health, two reviews indicate that discrimination may be more strongly associated with overall physical health aggregated across several domains and bodily systems (e.g., the cardiovascular, immune, and metabolic systems together), compared with isolated systems or disease outcomes. 4, 33 Nevertheless, studies examining perceived discrimination and specific illnesses have increased in recent years, with a particular focus on CVD risk.
Growing evidence indicates that perceived discrimination is associated with several measures of CVD risk. Blood pressure (BP) has been a primary focus in the literature, due to the distinct racial disparities in hypertension. To that end, a recent meta-analysis of 18 studies found a significant association between perceived discrimination and hypertension, particularly among Black adults. 3 Perceived discrimination is also associated with ambulatory assessments of BP in daily life, particularly higher nocturnal BP, an effect most evident among Black participants. 3, 36 Notably, perceived discrimination is not consistently associated with clinic measures of resting BP. 3, 36 Outside of the BP literature, perceived discrimination is also associated with preclinical markers of CVD risk and cardiovascular events. For example, higher general perceived discrimination is associated with greater preclinical atherosclerosis, as measured by intima media thickness, among Black but not White women. 37 Similarly, more perceived racial discrimination is associated with greater coronary artery obstruction among Black but not White men. 38 In addition, greater chronic exposure to general discrimination is associated with coronary artery calcification among Black women. 39 Perceived general discrimination also predicts increased risk for incident cardiovascular events (e.g., myocardial infarction, cardiac arrest, and stroke) across racial groups. 40 In contrast, perceived racial discrimination was not significantly associated with CVD-related death among a large sample of Black women. 41 In sum, considerable evidence suggests that perceived discrimination is relevant for CVD, although the findings are not consistent across all cardiovascular outcomes. However, the mechanisms by which perceived discrimination affects CVD are not well understood.
Existing conceptual models of perceived discrimination and health
Chronic and acute stress-based models. Existing conceptual models propose that perceived discrimination affects health through both acute and chronic stress-related effects on multiple physiological systems. Acute effects of perceived discrimination are typically described using a stress reactivity framework. Stress reactivity here refers to an individual's physiological response from a resting or basal state to a period of exposure to an acute mental or physical stressor. In general, existing models suggest that experiences of perceived discrimination evoke acute physiological responses (e.g., increased BP and heart rate (HR)) that eventually confer a greater health risk. 4 Notably, however, individuals differ significantly in the magnitude of these responses. Exaggerated and prolonged physiological reactivity may occur across multiple physiological systems 42 and responses across these systems are often intercorrelated. [43] [44] [45] Such responses are thought to influence health, including individual differences in vulnerability to CVD. 46, 47 For example, heightened cardiovascular and inflammatory reactivity predict incident hypertension 48 and larger endocrine responses are associated with a greater degree of coronary artery calcification. 49 Based on the reactivity framework, discriminationhealth models suggest that past experiences with discrimination can impact an individual's characteristic physiological reactivity to new acute stressors. 50, 51 This hypothesis extends from the stress literature, which proposes that background stressors may moderate physiological reactivity to new stressors, leading to either exaggerated or blunted responses. [52] [53] [54] It is not entirely clear how these changes occur. Some suggest that exposure to past discrimination may cause heightened vigilance for new stressors; such vigilance may lead to heightened reactivity in anticipation of and during new stressors. 55 Others suggest that chronic perceived discrimination causes lasting alterations in physiological stress systems, leading to exaggerated or blunted responses to new stressors. 56 Relatedly, models of chronic stress and health have been applied to perceived discrimination and health. Broadly, chronic exposure to psychosocial stress is thought to cause dysregulation across multiple physiological systems, eventually resulting in pathophysiology (e.g., CVD). 57, 58 For example, the allostatic load model proposes that the cumulative effects of chronic stress lead to "wear and tear" on physiological stress systems; this wear and tear may cause exaggerated or blunted responses to stress, alterations in critical physiological feedback loops that maintain homeostasis across contexts, and ultimately heightened risk for chronic disease. 59, 60 Thus, perceived discrimination might have chronic effects on neurobiological mediators through dysregulation across multiple physiological systems, ultimately contributing to a greater risk for CVD.
Psychosocial pathways. In addition to existing stress-based models, several other psychosocial factors are thought to drive or modify the relationship between perceived discrimination and physical health. Psychological responses have been proposed to both mediate and moderate the relationship between perceived discrimination and health. 25, 34 There is extensive prior literature linking perceived discrimination with a variety of measures of psychological distress and reduced well-being. 4, 25, 33, 34 Two meta-analytic reviews indicate that perceived discrimination is most robustly associated with symptoms of depression and anxiety. 25, 34 Importantly, depression and anxiety are both associated with dysregulation in the physiological stress systems described above; they also predict and are often comorbid with CVD. [61] [62] [63] As such, these mental health variables provide a plausible pathway from perceived discrimination to CVD. Beyond depression and anxiety, meta-analytic reviews also indicate that perceived discrimination is associated with reduced self-esteem and lower levels of positive affect. 25, 34 Although these relationships were less robust than those with depression and anxiety, reduced self-esteem and positive affect may also contribute to the link between perceived discrimination and CVD risk.
The relationship between perceived discrimination and health may also be moderated by individual differences in coping and social support. Theoretically, effective coping and social support are proposed to buffer the relationship between perceived discrimination and both physical and mental health outcomes, such that these factors reduce or eliminate negative outcomes for individuals exposed to greater discrimination. 4, 15 The literature on coping with racism was reviewed by Brondolo and colleagues, 15 who examined three approaches to coping with racism: racial identity development, social support seeking and availability, and anger expression and suppression. The authors reported that none of the examined coping approaches had a clear and consistent buffering effect on physical or mental health outcomes. Each coping strategy did appear to modify the relationship between perceived discrimination and health outcomes, just not in a consistent direction. The authors also proposed an integrative conceptual model, emphasizing that discrimination is a complex stressor that likely requires a range of different coping strategies over time. Because existing research tends to examine individual coping strategies in isolation, it is difficult to measure the benefits and drawbacks of combining different coping approaches.
The moderating roles of coping and social support were also examined in a meta-analytic review by Pascoe and Smart Richman. 4 For coping behavior, findings varied across analyses but there was some evidence that problem-focused or active coping strategies buffered the relationship between perceived discrimination and health. In contrast, emotion-focused or passive coping strategies seemed to exacerbate the association between perceived discrimination and poor health outcomes in several studies. For social support, most studies did not find that social support buffered the relationship between discrimination and health. The authors note that some types of social support may be beneficial for certain individuals in specific circumstances, but a consistent pattern did not emerge from the studies included in their meta-analysis.
Taken together, coping ability and social support are proposed as moderators of the relationship between perceived discrimination and health, but evidence is somewhat mixed for the specific effects of these moderators and their role in the pathway between perceived discrimination and CVD risk. Further work in this area is needed, particularly studies examining a broad range of coping methods and how individuals combine or utilize them to manage discrimination as a stressor.
Health behaviors. Perceived discrimination may also affect health via alterations in health behaviors. This could occur through multiple pathways. First, individuals may use health behaviors to cope with discrimination-related stress. Negative health behaviors (e.g., smoking, substance use, and unhealthy diet) may alleviate the emotional and mental toll of perceived discrimination, but have negative consequences for physical health. 64 Second, a greater exposure to discrimination may deplete self-regulatory capacity and thus decrease the ability to maintain positive health behaviors (e.g., sleep and exercise) and limit negative health behaviors (e.g., smoking and alcohol use). 65, 66 Regardless of the pathway, perceived discrimination may affect physical health through alterations in health behaviors. Indeed, a recent meta-analysis found that greater perceived discrimination was associated with more negative health behaviors and fewer positive health behaviors. 4 Since that meta-analysis, several reviews and new studies have assessed the relationship between perceived discrimination and various health behaviors. In our review, we will summarize this recent work to determine whether findings are consistent with Pascoe and Smart Richman's 4 meta-analytic conclusions.
Brain-body pathways linking stress and physical health. These existing models of perceived discrimination and health provide for an overall conceptual framework of how perceived discrimination might relate to health, but they lack specificity regarding biological mechanisms related to CVD risk. To achieve greater specificity, we can also consider models of brain-body pathways linking psychosocial stress and physical health. In this regard, recent models have conceptualized psychosocial stress as a process instantiated in brain systems that jointly (1) appraise the meaning of internal and external events (e.g., instances of unfair treatment) and (2) control physiological stress responses via bidirectional feedback loops. Two recent reviews summarize this literature, 67, 68 describing the brain systems that are involved in appraising stressful experiences and directing peripheral physiological responses. Briefly, both reviews propose that psychosocial stressors are processed by neural appraisal systems to determine whether the stressor poses a threat; these appraisal systems then communicate with networked brain regions that more directly or jointly regulate physiological stress systems. Gianaros and Wager's 67 model further postulates that physiological stress responses trigger afferent feedback to these same brain systems to regulate the magnitude and duration of the peripheral response. These brain-body models have primarily been applied to more general psychosocial and cognitive stress processing. However, these brain systems are part of broader intrinsic neural networks 69, 70 that could contribute to the psychosocial and cognitive processes involved in experiencing and responding to discrimination (see below). Thus, these same systems may be involved in processing perceived discrimination and social exclusion. 56, 71 Below, we integrate concepts derived from brain-body models of stress physiology with existing models of perceived discrimination and health. Taken together, brain-body models and early neuroimaging evidence may thus enhance our understanding of the biological mechanisms that link perceived discrimination to CVD risk. Accordingly, the aim of the following discussion is to use a health neuroscience approach to explore the neurobiological pathways by which perceived discrimination might "get under the skin" to impact CVD risk.
Interim summary and open questions about the neurobiology of discrimination and cardiovascular health
In summary, there are clear racial disparities in CVD that may be partially driven by stress-related factors such as perceived discrimination. Although previous reviews have detailed the association between perceived discrimination and CVD risk factors, 3, 36, 72 these reviews focus almost exclusively on cardiovascular measures. Importantly, psychosocial stress affects multiple physiological systems (e.g., autonomic, immune, and HPA systems); moreover, exaggerated stress-related reactivity across these systems is also linked with CVD. This suggests that a multisystem approach may improve our understanding of the link between perceived discrimination and CVD. Thus, below, we provide a review of the literature on neurobiological factors across multiple systems that may contribute to the association between discrimination and CVD risk. In doing so, we (1) review the literature on perceived discrimination and neurobiological mediators of CVD risk; (2) review relevant health behaviors and possible moderators of the relationship between discrimination and neurobiological mediators of CVD risk; (3) discuss whether the empirical evidence supports existing conceptual models and integrate this literature into an updated model; and (4) summarize the limitations of the existing literature and suggest future directions to address these limitations.
Search and inclusion criteria
Studies were identified through literature searches using PubMed and PsycINFO. The searches used combinations of the following key terms: discrimination, discriminatory, racism, racist, racial bias, unfair treatment; cardiovascular, stress, stressor, acute, laboratory, reactivity, responsivity, vagal, blood pressure, heart rate, vascular; cortisol, HPA, glucocorticoid; inflammation, interleukin (IL-6), C-reactive protein (CRP), immune, cytokine; neural, brain, neuroimaging, exclusion, rejection. In addition, we examined reference lists of all identified papers to find other potentially relevant studies. These searches were not limited to a specific date range, with one exception: the cardiovascular reactivity studies were limited to studies published after 2002, as the literature was reviewed in 2003. 72 Studies identified with these search terms were screened for inclusion in the review. To be selected, each study had to include (1) a measure of perceived discrimination or an experimental manipulation to evoke feelings of discrimination and (2) a biological measure relevant to CVD risk. Due to a small size of the literature linking perceived discrimination with brain activity and other neural correlates, inclusion criteria for the neural section were more lenient. Specifically, studies had to include (1) a measure of perceived discrimination or an experimental manipulation to simulate discrimination or exclusion/social rejection and (2) a measure of brain activity or structure. Where necessary, we also summarize previously published reviews. All studies included in the review were peer-reviewed and published in an English language journal.
Perceived discrimination and neurobiological mediators of CVD risk
Introduction to relevant systems Central and peripheral physiological stress systems are pertinent to our understanding of the neurobiological mediators of CVD risk. Exposure to psychosocial stress activates the autonomic nervous system (ANS) and HPA axis. Within the ANS, stress exposure typically leads to upregulation of the sympathetic nervous system (SNS) and downregulation of the parasympathetic nervous system (PNS). 73 The HPA axis stress response is initiated by the hypothalamus, which stimulates the release of adrenocorticotropic hormone (ACTH) from the pituitary gland into peripheral circulation. ACTH travels to the adrenal cortex, where it stimulates the secretion of glucocorticoids (e.g., cortisol). 74 The ANS and HPA axis exert powerful influences over the immune system. For example, activation of these systems can trigger fluctuations in levels of inflammatory cytokines in the peripheral circulation 68, 75, 76 As such, stress has wide-ranging effects on the immune system, in some cases leading to immune suppression and, in other cases, immune enhancement.
Cardiovascular system
The relationship between perceived discrimination and both resting and ambulatory measures of cardiovascular function has been previously reviewed. 3, 36 As such, our review focuses primarily on cardiovascular reactivity. Cardiovascular reactivity refers an individual's cardiovascular response to acute stress, as measured by one more indicator of cardiovascular function (e.g., BP and HR). In most laboratory studies of cardiovascular reactivity, cardiovascular responses are evoked by acute stress tasks involving time pressure, negative performance feedback, social evaluation, and other aversive conditions. These tasks are often used as acute psychological challenges in reactivity studies, as they (1) have motivational relevance due to potential positive or negative consequences for the participant and (2) require engagement of cognitive or behavioral coping responses to successfully complete the task. 77 In the studies reviewed here, some use more general stressor tasks, while others specifically aim to evoke feelings of discrimination. These tasks will be discussed below.
The studies included in our review include a variety of cardiovascular measures. BP and HR typically increase in response to acute stress, reflecting increased SNS and decreased PNS activity. 73 High-frequency heart rate variability (HF-HRV) typically decreases in response to acute stress, indicating decreased parasympathetic cardiac activity. Pre-ejection period (PEP) tends to shorten in response to acute stress, reflecting increased SNS activity and increased cardiac contractility. There are several other less commonly used cardiovascular measures, such as cardiac output (CO), stroke volume (SV), and total peripheral resistance (TPR). Each of these measures shows variable responses to acute stress, thought to be dependent on an individual's appraisal of the stressor as a threat or as a challenge. 78, 79 Notably, CO, SV, and TPR have not been as reliably related to CVD risk as measures of HR, BP, and HF-HRV.
Relationship of cardiovascular reactivity with CVD risk. Individuals who show exaggerated psychological and physiological responses are thought to be at a greater risk for CVD. 47, 80, 81 Indeed, exaggerated cardiovascular reactivity to acute stress is associated with increased risk for CVD mortality 82 and poor cardiovascular risk status, as defined by a combined metric of risk for hypertension, subclinical atherosclerotic progression, and clinical cardiac events. 83 This association is particularly strong for the association between BP reactivity and hypertension risk. There is less consistent evidence for an association between other measures of cardiovascular reactivity (e.g., HR and HF-HRV) and CVD risk.
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Race differences. Researchers have long proposed that disparities in CVD are due in part to greater cardiovascular reactivity among Black individuals. 84 Contrary to this hypothesis, however, Black participants do not consistently show greater cardiovascular reactivity to acute stress compared with other racial groups. 85 Race differences in cardiovascular reactivity may vary by stressor type or chronic stress exposure. 50 Thus, there may be race differences in cardiovascular reactivity as a function of exposure to discrimination. Here, we review evidence for the relationship between perceived discrimination and cardiovascular reactivity, exploring possible race differences where possible.
Relationship with perceived discrimination. An early literature examining perceived discrimination and cardiovascular reactivity was reviewed by Brondolo and colleagues. 72 This review came to three primary conclusions. First, laboratory simulations of racial discrimination generally evoke heightened cardiovascular responses. Second, Black participants exhibit greater cardiovascular reactivity when exposed to race-related compared with nonracial stressors. Third, individuals reporting more past perceived discrimination show heightened cardiovascular reactivity to both race-related and nonracial stressors. Since that review, there have been 12 new studies, utilizing a wide range of laboratory paradigms. These studies can be broadly divided into two categories: (1) studies examining reactivity to race-related stressors and (2) studies examining history of perceived discrimination in relation to reactivity to new stressors.
Studies examining reactivity to race-related stressors. Six studies fell into the first category: studies examining reactivity to race-related stressors (Table 1) . In some studies, participants had to recall, read, or respond to a scenario depicting race-related discriminatory treatment. 50, 86, 87 In other studies, participants were treated negatively by a confederate to simulate discrimination in the laboratory. 55, 88, 89 Consistent with the previous review, all six studies found that laboratory simulations of discrimination evoked cardiovascular reactivity. This effect was evident for several cardiovascular indicators: acute stress generally evoked increased BP and HR, decreased HF-HRV, and shortened PEP. Taken together, these effects suggest stressor-evoked increases in SNS activity and decreases in PNS activity.
Several factors predicted magnitude of cardiovascular responses, including race of the confederate and whether the participant attributed negative treatment to racial discrimination. In studies where participants were treated poorly by a confederate, cardiovascular responses were greater if the confederate was a different race than the participant. 88, 89 Effects were also more pronounced if a confederate of different race was perceived as clearly prejudiced. 55 Racial attributions were also related to cardiovascular responses: two studies found that attributing negative treatment to racial discrimination was associated with greater BP reactivity. 50, 87 r Black women more likely to make racial attributions after task and racial attributions were related to lifetime discrimination.
Racial attribution

Continued
r Racial attributions
were not associated with reactivity.
BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; HR, heart rate; HRV, heart rate variability; TPR, total peripheral resistance; PEP, pre-ejection period; CO, cardiac output; SV, stroke volume; HF-HRV, high-frequency heart rate variability; GPA, grade point average; SES, socioeconomic status.
It is currently unclear whether there are race differences in magnitude of response, as only two studies tested multiracial samples. In the first study, Black participants exhibited greater BP reactivity to a race-related stressor than to a nonracial stressor, whereas White participants showed no difference in reactivity by stressor type. 50 In the second study, there were no race differences in cardiovascular reactivity to receiving negative feedback from a confederate; however, Black participants who received positive feedback from a White confederate exhibited lower CO and higher TPR, whereas White participants receiving positive feedback from a Black confederate did not show this effect. 89 Thus, there may be race differences in cardiovascular reactivity, but they seem to vary based on stressor type.
Studies examining history of discrimination and reactivity to new stressors.
Six studies fell into the second category: studies examining history of perceived discrimination and reactivity to new stressors. The main aim of these studies was to examine whether a greater history of perceived discrimination is associated with differences in reactivity to new stressors. Three studies assessed the relationship between perceived discrimination and cardiovascular reactivity to a racerelated stressor. In one study, higher perceived discrimination was associated with greater HF-HRV reactivity, but not BP or HR reactivity. 90 Another study did not find a main effect of past perceived discrimination on BP reactivity; however, this study found an interaction between perceived discrimination and John Henryism, a coping strategy that involves actively managing long-term stressors with high levels of effort. Specifically, John Henryism was only associated with lower BP among women reporting low perceived discrimination. 91 In the third study, the association between history of perceived discrimination and cardiovascular reactivity varied by participant race; specifically, White participants exhibited a positive association, Latino participants showed a negative association, and Black participants showed no association. 92 Three studies assessed the relationship between past perceived discrimination and cardiovascular reactivity to a nonracial stressor. Two studies found that perceived discrimination was positively associated with BP and HR reactivity, 51, 93 while the third study found no main effect of perceived discrimination on BP reactivity. 94 Two of these studies reported that social support moderates the effect of perceived discrimination on cardiovascular reactivity. 93, 94 In a single multiracial sample, the effects of perceived discrimination on cardiovascular reactivity were more pronounced for Black compared with White participants. 51 Overall, these studies suggest that past perceived discrimination is related to magnitude of cardiovascular reactivity to new stressors; however, this relationship may be moderated by participant race or coping methods.
Summary of cardiovascular reactivity studies. In summary, studies of discrimination and cardiovascular reactivity have produced a number of results. In studies, evoking feelings of discrimination in the laboratory, recalled and simulated discriminatory treatment evoke increases in cardiovascular reactivity. These results are consistent with the previous review 72 and with the hypothesis that discrimination may impact cardiovascular health through cardiovascular reactivity to discriminatory treatment. Studies examining past perceived discrimination and reactivity to new stressors indicated that history of perceived discrimination is associated with exaggerated reactivity to new stressors. However, this association varies by race and coping-related factors. These studies conditionally support the hypothesis that past perceived discrimination impacts cardiovascular reactivity to new stressors.
Comments on study quality. There are several methodological issues with this literature. First, stressor tasks were highly heterogeneous, including a variety of tasks from mental arithmetic to simulations of racial discrimination in the laboratory. Second, earlier studies used physiological recording methods that are inconsistent with current guidelines (e.g., short recording periods or few measurements). 50, 91, 93, 94 This issue has been remedied in more recent studies. Third, there were several sampling issues. Sample sizes were relatively small, ranging from 32 to 165 participants. The vast majority of studies used undergraduate samples that were homogenous in race and gender. Most studies included Black only or Black and White participants, with only two studies including Latino participants and none with Asian or other racial/ethnic groups. This limited our ability to generalize findings, draw reliable conclusions about race differences, and compare findings across racial groups within each study.
HPA axis
The HPA axis is another pathway that may link perceived discrimination with CVD risk. Peripheral release of cortisol, the HPA axis' main output hormone, follows a diurnal pattern. Cortisol levels are highest in the morning, peaking approximately 30-45 min after waking (cortisol awakening response (CAR)), then gradually decreasing throughout the day, reaching a nadir in the middle of the night. Cortisol levels can be measured in several ways. Early research focused on basal cortisol levels at individual points and cortisol levels averaged across relatively long periods. 95 However, more recent research emphasizes individual differences in diurnal cortisol patterns. These measures include the CAR and diurnal slope (i.e., rate of decline from morning to evening). 95 A strong diurnal rhythm with a clearly defined CAR and characteristic decline over the day is thought to reflect healthy HPA axis functioning. 96 Psychological stress is associated with cortisol fluctuations. In general, psychological stress activates the HPA axis, stimulating the release of cortisol in the periphery. Cortisol has downstream effects that are thought to help mobilize physiological resources to prepare for an ensuing threat. 74, 95 Different types of stress have varying effects on the HPA response. Acute stressors typically evoke increases in cortisol levels. In the short term, acute cortisol reactivity is thought to be an adaptive response to stressors, in preparing the body to respond to potential threats. 97 However, sustained elevations in cortisol may lead to HPA dysregulation and tissue damage. Indeed, chronic stress is associated with diminished cortisol activity, blunted cortisol reactivity, 98 and flattened diurnal cortisol slope (i.e., lower waking levels and higher evening levels).
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Relationship of HPA axis with CVD risk. Altered HPA axis activity is associated with CVD risk, but the relationship varies across HPA measures. Diurnal cortisol slope measured throughout the day is most consistently associated with CVD risk. Specifically, flatter diurnal slope is associated with a greater CVD risk, as measured by coronary artery calcification 100, 101 and cardiovascular mortality.
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Associations between CVD risk and other HPA axis measures are inconsistent. Abnormal cortisol response upon awakening and total cortisol output (e.g., area under the curve) are not consistently associated with CVD. [101] [102] [103] Additionally, measurements at single time points are unreliable and difficult to interpret. 95, 104, 105 Thus, flatter diurnal slope appears to be the only HPA axis metric that is both reliable and consistently related to CVD risk. For this reason, our review will focus primarily on studies examining the relationship between perceived discrimination and diurnal cortisol slope.
Race differences. Diurnal cortisol slope differs by race. Compared with White participants, Black participants typically exhibit a flatter diurnal cortisol slope (i.e., a less steep decline throughout the day), with lower morning levels and higher evening levels. 106, 107 This pattern has been observed across the lifespan from preadolescence to adulthood. [106] [107] [108] [109] [110] [111] It is unclear whether race differences in diurnal cortisol slope extend to other racial groups. For example, studies including Latino participants report flatter, steeper, and similar slopes for Latino compared with White and Black groups. 107, 110, 111 Relationship with perceived discrimination. A portion of literature on perceived discrimination and HPA axis function was recently reviewed in two separate papers. 56, 112 In the first review, 56 specifically focused on racial discrimination, the authors concluded that racial discrimination may affect mental and physical health through alterations in HPA axis function; however, this review did not draw specific conclusions for diurnal cortisol slope.
As noted, our review focuses only on studies reporting associations between perceived discrimination and diurnal cortisol slope; thus, only one study from the Berger and Sarnyai review is also reviewed here. 56 The second review 112 was not specifically focused on racial discrimination and thus included studies examining discrimination related to sex, sexual orientation, age, weight, age, and HIV status. However, this review did draw conclusions about the relationship between perceived discrimination and diurnal cortisol slope. Specifically, they found that the large majority of studies report an association between greater perceived discrimination and flatter diurnal cortisol slope. In our review, we discuss several of the same studies reviewed by Busse and colleagues;
112 however, our conclusions are based only on studies that examined racial discrimination or general discrimination.
Five studies assessed the relationship between perceived discrimination and diurnal cortisol slope ( Table 2 ). Four studies found that greater perceived discrimination was associated with flatter diurnal cortisol slope among at least one racial group. 108, 109, 113, 114 This association was apparent with both racial 108, 113 and general discrimination. 109, 114 The single longitudinal study reported that greater perceived racial discrimination measured over 20 years predicts flatter diurnal cortisol slopes later in life. 113 In contrast to the other four studies, one study of preadolescents found no association between perceived racial discrimination and diurnal slope; 111 this suggests that the relationship between perceived discrimination and cortisol slope may not be evident earlier in life or that perceived discrimination is less reliably measured in children. Thus, greater perceived discrimination seems to be associated with a flatter diurnal cortisol slope among adults, but additional work is needed to determine whether this relationship exists in younger samples.
There were no consistent race differences in this relationship across studies. Two of the reviewed studies assessed racial discrimination; these studies both found a significant association between higher perceived discrimination and a flatter diurnal slope for Black and White participants. 108, 113 The other two studies assessed general discrimination; these studies reported contradictory results: in one, greater perceived discrimination predicted flatter diurnal slopes among racial minority participants but not White participants; 114 in the other study, greater perceived discrimination predicted flatter slopes among White participants but steeper slopes among low socioeconomic status (SES) Black participants. 109 Taken together, these four studies suggest that the relationship between perceived discrimination and diurnal cortisol slope does not vary consistently by race.
In summary, greater perceived discrimination is associated with flatter diurnal cortisol slope among adult samples. Moreover, initial longitudinal evidence suggests that perceived racial discrimination prospectively predicts future diurnal cortisol slope. Based on existing evidence, this relationship does not vary by race.
Comments on study quality. There are several methodological concerns related to cortisol measurement and sampling. The reviewed studies assessed diurnal slope using 3-6 measurements per day over 3-7 days; however, some methodological guidelines suggest at least 6 days for highest reliability in diurnal slope calculation. 105 Another concern is that participants collect their own saliva samples outside of the laboratory; although sample collection times were self-reported by participants, most studies were not able to objectively monitor saliva collection. Aside from cortisol collection, racial diversity between and among samples was limited. The majority of studies included only Black and White participants, with little representation of other racial and ethnic groups.
Immune system
The immune system is another potential stressrelated pathway linking perceived discrimination and CVD risk. Although psychosocial stress affects numerous facets of the immune system, inflammatory processes provide the most plausible link to CVD. The inflammatory response is part of the immune system's initial reaction to injury or a foreign invader. Phagocytes in the tissue and bloodstream initiate the inflammatory cascade by secreting proinflammatory cytokines, signaling proteins that act as immune messengers and coordinate local and systemic inflammatory processes. Circulating levels of these cytokines are commonly assessed as a metric of ongoing or systemic inflammatory processes in the body. The most commonly assessed inflammatory markers are the IL-6 and the downstream marker CRP. Short-term increases in inflammation are an adaptive and critical component of the immune response; however, prolonged elevated levels of systemic inflammation can cause tissue damage and contribute to the development of chronic diseases, such as CVD. 115, 116 Relationship with CVD risk. Chronic inflammatory processes drive atherosclerosis, the chief pathophysiological basis of CVD. 117, 118 Atherosclerosis is initiated by damage to the endothelial lining of blood vessels. 118 This damage enables migration of monocytes into the arterial wall, where monocytes mature into macrophages and secrete cytokines and growth factors that maintain the vascular inflammatory response. 119 These chronic processes occur over decades, increasing the risk for clinical CVD. 119, 120 Adding to this pathophysiological evidence, epidemiological work shows that heightened levels of circulating inflammatory markers (e.g., IL-6 and CRP) confer increased risk for CVD incidence and mortality. [121] [122] [123] [124] [125] Given this evidence, our review of perceived discrimination and immune measures focuses on circulating inflammatory markers.
Race differences. Systemic inflammation differs relatively consistently by race. Black individuals tend to have elevated levels of both CRP and IL-6 compared with White individuals. [126] [127] [128] Latino individuals may also have higher CRP than White individuals; 128, 129 however, this finding is not consistent across all studies. 127 In contrast, Chinese and Japanese American individuals may have lower CRP compared with White individuals. 127, 129 These race differences generally correspond with race differences in CVD. 8, 130 Relationship with perceived discrimination. Eight studies assessed the relationship between perceived discrimination and systemic inflammation ( Table 3) . The majority of studies found a positive association between perceived discrimination and systemic inflammation. Greater perceived discrimination was associated with higher levels of CRP, [131] [132] [133] [134] IL-6, 135 and a composite of multiple cytokines. 136 This association was evident in both cross-sectional [132] [133] [134] [135] and longitudinal studies with up to a 7-year follow-up. 131, 136 However, the relationship between perceived discrimination and systemic inflammation varied within studies based on several factors, including body composition, gender, and race. Three studies found that adjusting for body composition (e.g., body mass index (BMI)) attenuated the relationship between perceived discrimination and systemic inflammation. 131, 134, 137 In one study, perceived discrimination only predicted CRP over 7 years among nonobese women. 131 In another, BMI statistically mediated the association between perceived discrimination and IL-6. 135 Thus, it is unclear whether body composition moderates, mediates, or confounds the relationship between perceived discrimination and systemic inflammation.
The relationship between perceived discrimination and systemic inflammation may also vary by gender. The two largest studies found a positive relationship between perceived discrimination and systemic inflammation among women, but no consistent relationship among men. 132, 135 The reason for these gender differences is unclear.
Outcomes did not differ consistently by race or type of discrimination measure (e.g., general versus racial discrimination). Among the studies with multiracial samples, 131, 132, 135, 138, 139 only one study found significant race differences. This study found a positive linear relationship between perceived racial discrimination among White women, but a curvilinear relationship among Black women; specifically, Black women reporting moderate levels of racial discrimination had the highest levels of CRP. 132 This pattern was not observed in other studies. There were no systematic differences in findings between studies based on type of discrimination measure. Taken together, this evidence suggests that perceived discrimination has a similar relationship with systemic inflammation regardless of race or attribution of discrimination to race.
Not all studies found a significant association between perceived discrimination and systemic inflammation across all participants. 135, 138, 139 Each of these studies had notable differences from other reviewed studies that may explain this inconsistency. One early study measured perceived discrimination using a single question with a dichotomized response; this question likely failed to capture the complexity of exposure to discrimination. 139 The second study had one of the smallest samples sizes (N = 60) and may have been underpowered to detect the magnitude of association between perceived discrimination and IL-6. 138 The third study had a very large sample that reported a significant positive association between perceived discrimination and IL-6 among women, but did not find an association with CRP in the full sample. 135 The reason for this null finding is unclear, but could be driven by the sample's inclusion of older participants (up to 85 years) compared with other samples. Older age is related to higher systemic inflammation due to a variety of factors, including greater prevalence of inflammatory diseases. 140 Thus, there are several other variables that might confound the relationship between perceived discrimination and systemic inflammation in an older sample.
In summary, this evidence suggests an association between perceived discrimination and systemic inflammation, such that greater perceived discrimination is associated with higher CRP and IL-6. This association may vary by body composition and gender, but the nature of these variations requires further study. This relationship did not differ consistently by race or discrimination measure, suggesting that greater perceived discrimination is linked with poorer inflammatory status across racial groups and racial attributions.
Comments on study quality. This literature has two major limitations. First, many studies were homogenous in race and gender. This prevented full consideration of possible race and gender differences. Second, BMI seemed to play a significant role in the association between perceived discrimination and systemic inflammation, but it was not possible to determine the nature of this role.
Neural
Brain systems plausibly link perceived discrimination to CVD. The reason for this postulate is that instances of discriminatory events must be encoded, construed, represented, and appraised as intermediary processes instantiated at the neural level. These processes in turn putatively trigger stress-related alterations in peripheral physiology. Unfortunately, there is limited evidence examining the association between perceived discrimination and such neural processes. For example, a largely open question is how discrimination engages brain systems that are thought to be involved in stress appraisals and peripheral physiological regulation. However, previous work on brain systems linking psychosocial stress with health provides a framework for this new area of research, enabling the formulations of empirically testable predictions and directions for future work. Additionally, there are several recent neuroimaging studies on social exclusion or rejection induced by laboratory manipulation-which are arguably instances of unfair treatment. Importantly, social exclusion is just one facet of perceived discrimination and does not encompass the full complexity of experiencing discriminatory treatment. Nonetheless, these studies can inform our early understanding of brain systems involved in perceived discrimination. Existing studies largely utilize functional magnetic resonance imaging (fMRI) to characterize neural activity during social exclusion.
To replicate social exclusion during fMRI, a common paradigm is to have participants play a computerized game called Cyberball in which they toss a virtual ball with two other players. 141, 142 Participants are led to believe they are playing with two other participants; in reality, the game is rigged and they are playing against the computer. In the first round (i.e., inclusion), participants receive and throw the ball equally with other players. In the second round (i.e., exclusion), participants receive the ball from the other players during the first 10 tosses but are excluded for the duration of the round. Cyberball is frequently used to simulate social exclusion and typically evokes feelings of rejection/exclusion and varying degrees of psychological distress. 71, 142 To characterize brain systems involved in social exclusion, researchers examine differences in neural activity between the inclusion and exclusion conditions, as well as the correlation between these differences and exclusion-related distress. Such findings provide insight into the brain systems involved in social exclusion, which are likely related to brain systems relevant to perceived discrimination.
Brain systems and peripheral physiology. Psychosocial stress is thought to be linked with physical health risk via brain systems that control peripheral physiological stress responses. These proposed pathways have been summarized in two related brain-body conceptual models. 67, 68 Gianaros and Wager's 67 model focuses on bidirectional brainbody pathways that link psychosocial stress with CVD risk via cardiovascular stress reactivity. At the neural level, environmental stimuli are interpreted by appraisal systems in the brain. If a stimulus is interpreted as stressful, or as exceeding one's coping abilities and resources, this information is relayed through subcortical and brainstem structures. The latter systems regulate physiological stress systems (e.g., the ANS) through visceromotor pathways, directing peripheral physiological responses to psychological stress. In turn, physiological stress responses send afferent signals back up to the central nervous system to control the magnitude and duration of peripheral physiological responses, as well as to shape stress appraisals.
Gianaros and Wager's 67 review proposed specific brain systems involved in appraisal and visceral control. In particular, regions of the prefrontal cortex (PFC) and anterior cingulate cortex (ACC) are central to stress appraisal and subsequent autonomic control. These regions can be further subdivided into regions that correspond with pro-SNS/threat and pro-PNS/antithreat responses: pro-SNS/threat responses correspond with activation the anterior mid cingulate cortex (aMCC) and the pregenual anterior cingulate cortex (pgACC); pro-PNS/antithreat responses correspond with activation of the ventral medial prefrontal cortex (vmPFC) and the subgenual anterior cingulate (sgACC). These PFC and ACC regions are linked with the insula and amygdala, as well as subcortical and brainstem regions (e.g., thalamus, periaqueductal gray, and pons) that more directly regulate physiological stress responses.
A related model was proposed by Muscatell and Eisenberger. 68 Here, brain systems involved in threat and safety processing, as well as self and social cognitive processing, project to regions that generate ANS and HPA axis stress responses. This model also focuses largely on PFC and ACC regions, as well as the insula and amygdala. Specifically, increased stressor-evoked activity in the dorsal anterior cingulate (dACC a ), anterior insula (AI), and amygdala corresponds with heightened SNS responses; conversely, greater stressor-evoked activity in the vmPFC is associated with lesser increases in SNS activity. Similarly, greater stressor-evoked dACC activity is associated with heightened cortisol responses, while increased activity in the vmPFC is associated with decreased cortisol responses. These hypothesized pathways largely agree with Gianaros a The region referred to as dACC by Muscatell and Eisenberger 68 has significant overlap with the region referred to as the aMCC by Gianaros and Wager. 67 and Wager's proposed pro-SNS/threat and pro-PNS/antithreat divisions.
In addition to these conceptual models, a network-based approach may also provide a framework with which to understand the relationship between perceived discrimination and brain activation. Such an approach suggests that mental states are constructed from a set of more basic, interacting, psychological operations; these general operations correspond with intrinsic networks that involve several different brain areas. 69, 70 For example, a basic operation of the so-called salience network (SN), which encompasses areas of the cingulate, amygdala, and insula, is thought to utilize homeostatic information to guide attention, affect, and motor behavior. As such, specific emotions, cognitions, and perceptions are constructed from interactions within and between brain systems comprising this network and affecting the functionality of this network. Experiencing discrimination or social exclusion is a complex experience, often involving a range of emotional, perceptual, and cognitive processes. Thus, we would expect several intrinsic networks to be involved. Specifically, we would expect involvement of at least three networks: the SN, as mentioned above; a so-called limbic network (LN), whose basic operations are affect generation and visceromotor regulation principally via the vmPFC; and the default mode network (DMN), whose basic operations involve representing past experiences to put present experiences into context and to support prospective thought and action, principally via anterior and posterior cortical regions along the midline of the cerebral hemisphere. 69 Thus, while we discuss associations between specific brain regions and perceived discrimination or social exclusion, these individual regions fit into larger scale networks that may interact to drive the experience of discrimination and individual differences in responding to discrimination. Indeed, aspects of systemic physiology that have been linked to CVD risk and discrimination have been separately linked to activity patterns in these networks. [143] [144] [145] Relationship between neural systems and CVD risk. Neural activity in the brain system discussed by Gianaros and Wager 67 and Muscatell and Eisenberger 68 is associated with CVD risk. For example, an fMRI study of threat processing found that greater amygdala activity and functional connectivity between the amygdala and pgACC were associated with greater carotid intima media thickness, 146 although subsequent work with a larger sample failed to replicate an association between amygdala activity and preclinical atherosclerosis. 147 In that study, greater activity in the dACC during emotion regulation (cognitive reappraisal of negative stimuli) was associated with greater carotid intima media thickness and interadventitial diameter. 147 Additionally, recent work found that resting activity in the amygdala was associated with increased risk of CVD events. 148 Taken together, this evidence provides provisional and evolving support for a model by which individual differences in threat processing and appraisalrelated brain activation may become linked with CVD risk.
Relationship between brain activity and perceived discrimination or social exclusion. The literature on brain activity and perceived discrimination and social exclusion was recently reviewed. 56 This review focused primarily on possible neural pathways linking perceived discrimination with mental health. Briefly, their model proposed that chronic perceived discrimination leads to hyperactivated peripheral stress response systems (e.g., ANS and HPA axis). These peripheral systems send afferent autonomic and hormonal signals from the periphery to subcortical regions, which relay information to the PFC, ACC, and the SN (e.g., amygdala, dACC, mPFC, AI, and thalamus). This afferent signaling leads to altered function of the ACC, PFC, and SN, possibly relating to sustained hypervigilance, abnormal salience attribution, and ultimately greater susceptibility to psychosocial stress. Taken together, these changes may increase poor mental health outcomes. Here, we review much of the same literature, focusing instead on the implications of these findings for neurobiological mediators of CVD risk. Our approach is informed by previously described brain-body conceptual models. 67, 68 Three studies used the Cyberball task to examine brain activation during social exclusion compared with inclusion (Table 4 ). The first study reported greater activation in the dACC and right ventral PFC (rvPFC) during exclusion; moreover, psychological distress was positively correlated with dACC activity and negatively correlated with rvPFC activity. 149 Subsequent work found slightly different results, r sgACC activity correlated positively with self-reported distress; dmPFC activity correlated negatively with self-reported distress. r Greater anterior insula, dACC, dmPFC, and mPFC activity during observed exclusion associated with higher trait empathy.
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pgACC, pregenual anterior cingulate cortex; dACC, dorsal anterior cingulate cortex; rvPFC, right ventral prefrontal cortex; sgACC, subgenual anterior cingulate cortex; AI, anterior insula; vlPFC, ventrolateral prefrontal cortex; rACC, rostral anterior cingulate cortex; vmPFC, ventromedial prefrontal cortex; dmPFC, dorsomedial prefrontal cortex; mPFC, medial prefrontal cortex.
reporting greater activation in the insula, rvPFC, sgACC, and ventral striatum during exclusion. Here, psychological distress was positively correlated with insula and sgACC activity but negatively correlated with rvPFC, dmPFC, and ventral striatum activity. 150 The third study examined brain activity while participants observed another individual's exclusion. Across all participants, activity in the dmPFC, vmPFC, and precuneous was greater while observing exclusion. Highly empathetic participants also exhibited greater activation in the insula and dACC while observing exclusion. 151 In summary, processing of social exclusion seems to involve a network of regions of the ACC, PFC, and insula. Additionally, exclusion-related distress seems to be positively correlated with dACC, insula, and sgACC activity but negatively correlated with both ventral and dorsal PFC activity.
Two studies incorporated discrimination measures into their fMRI paradigms (Table 4 ). The first study used the same Cyberball paradigm, but led Black participants to believe they were being excluded by two White participants. 152 Afterward, participants were interviewed to assess psychological distress and whether they attributed exclusion to racial discrimination. Results paralleled and added to the social exclusion work. First, brain activation during race-related exclusion was characterized by greater activity in the ACC, PFC, and insula. Second, distress was positively correlated with dACC activity and negatively correlated with dorsal and ventral PFC activity. Finally, attributing social exclusion to racial discrimination was associated with less activity in the dACC and more activity in the rACC b . The final study is the only study to assess whether past perceived discrimination is associated with alterations in neural activity during stress. In this b The region referred to in this study as the rACC has significant overlap with the vmPFC and the region termed pgACC elsewhere. study, the authors compared neural activation during an acute stressor in ethnic majority versus ethnic minority participants. 153 Among ethnic minority individuals, ethnic group-related perceived discrimination was associated with greater stress-related activation of the pgACC and ventral striatum. This study also reported a significant mediation such that chronic stress mediated the relationship between perceived ethnic discrimination and functional connectivity of the pgACC and dACC. These results suggest that prior exposure to discrimination is associated with altered neural activation during acute stressors.
In summary, these studies indicate that experiences of social exclusion and perceived discrimination evoke activity in several regions proposed in brain-body models of psychosocial stress and physical health (e.g., regions of the ACC, PFC, and insula). Exclusion-related activation showed both positive and negative correlations with psychological distress, suggesting that some of the regions are involved in generating threat responses (dACC and insula), whereas other regions are involved in regulating threat responses (e.g., dorsal and ventral mPFC activity). In addition, prior exposure to perceived discrimination may be linked with altered stress reactivity in these same regions (e.g., pgACC and dACC).
Comments on study quality. There are several limitations to this literature. Notably, only two studies manipulated or measured perceived discrimination in relation to brain activation. The other studies were observational or examined individual difference correlations, preventing the researchers from drawing conclusions regarding the direction of the association. There are also several sample limitations. First, participants in the Cyberball studies were young adults or adolescents and thus may not be comparable to older samples. In addition, sample sizes were quite small, ranging from 13 to 80 participants. Finally, most samples were ethnically diverse but statistically underpowered to test for race differences.
Health behaviors
In addition to these neurobiological mediators, numerous health behaviors could plausibly link perceived discrimination and CVD. Here, we discuss two behaviors that are most prominent in the perceived discrimination literature: sleep and tobacco use. Importantly, these health behaviors are consistently associated with CVD risk and dysregulation in physiological stress systems. As such, these behaviors may contribute to the association between perceived discrimination and CVD. Beyond sleep and tobacco use, recent studies have also examined the relationship between perceived discrimination and other health behaviors (e.g., alcohol use, diet, and physical activity). We elected not to include these studies in our review for two primary reasons. First, the relationship between alcohol use and CVD risk is inconsistent, depending largely on the quantity, frequency, and type of alcohol consumed; this level of detail is not captured in the majority of existing studies examining perceived discrimination and alcohol use. Second, there are few studies examining the link between perceived discrimination and diet and physical activity (i.e., three studies each), indicating that additional work is needed before the emerging literatures on diet and physical activity can be meaningfully reviewed. Thus, the scope of this section is limited to sleep and tobacco use.
Sleep
Sleep may be one pathway linking perceived discrimination and CVD risk. Sleep quality, sleep disturbance, and both shorter and longer than average sleep duration are associated with heightened CVD risk. [154] [155] [156] In addition, psychosocial stress is associated with poor sleep. 157, 158 Like other psychosocial stressors, perceived discrimination could affect sleep through increased distress, mood disturbance, and vigilance for threat. Discrimination may also affect sleep through increased physiological arousal. For example, experimental sleep disruption leads to increased cardiovascular reactivity. 159 Additionally, stress-related HPA axis hyperactivity is linked with shorter sleep duration, decreased slow wave sleep, and increased sleep fragmentation. 157, 160 Moreover, sleep disturbances and disorders also predict HPA axis dysfunction. [160] [161] [162] This evidence suggests that psychosocial stress may trigger a cyclical relationship between HPA axis dysfunction and sleep.
Additionally, racial disparities in sleep characteristics parallel racial disparities in CVD. In general, Black individuals tend to have poorer sleep quality, shorter sleep duration, and greater sleep latency relative to White individuals. [163] [164] [165] [166] Moreover, recent work indicates that shorter sleep duration may partially account for racial disparities in HPA axis dysfunction, as measured by flatter diurnal cortisol slope. 162 Given these racial disparities, sleep seems to be a particularly relevant behavioral pathway linking perceived discrimination with CVD.
Evidence linking perceived discrimination with sleep characteristics was recently reviewed. 167 This systematic review summarized 17 studies and included several types of discrimination, including racial discrimination. The review revealed positive associations between perceived discrimination and poor sleep across discrimination assessments and sleep measures. The most consistent finding was a positive association between perceived discrimination and self-reported sleep difficulties (e.g., trouble sleeping, insomnia, and fatigue). This finding was reported in both cross-sectional and prospective studies, suggesting that perceived discrimination predicts future sleep difficulties. Perceived discrimination was also associated with shorter sleep duration in several studies, but this association varied by discrimination type and sleep measure. Among the four studies using objective measures of sleep (e.g., polysomnography), findings were less consistent; one study reported an association between perceived discrimination and shorter sleep, while three studies reported null associations. In summary, this systematic review indicated that greater perceived discrimination is associated with poorer sleep. However, additional studies using objective sleep measures are needed to further clarify these results. These findings support the assertion that sleep is one mediator of the relationship between perceived discrimination and CVD risk.
Tobacco use
As with sleep, tobacco use may link perceived discrimination and CVD risk. Tobacco use, such as cigarette smoking, is associated with heightened systemic inflammation 168, 169 and increased risk for CVD. 170, 171 Other psychosocial stressors are associated with increased cigarette use. 172, 173 Cigarette smoking may be a behavioral method used to cope with psychosocial stressors, including discrimination. 174 Race differences in smoking do not correspond with racial disparities in CVD. In fact, some reports indicate that tobacco use is more common among White than Black individuals. 175 Nevertheless, tobacco use may still link perceived discrimination with CVD risk.
Prior reviews examine the association between perceived discrimination and tobacco use. Perceived discrimination shows a consistent positive association with smoking status and smoking frequency. 19, 176 This relationship is evident for both current smoking status and smoking history. 19, 66 Additionally, recent findings suggest that the relationship between perceived discrimination and smoking varies by type of discrimination exposure. Specifically, recent racial stressors were more strongly associated with current smoking status, whereas chronic racial discrimination was associated with a higher frequency of smoking each day. 66 Overall, this literature indicates a positive relationship between perceived discrimination and tobacco use.
Summary of health behaviors
In summary, there seems to be an association between perceived discrimination and negative health behaviors. The findings for sleep and tobacco use are relatively consistent, such that perceived discrimination is linked with poor sleep and increased smoking. Taken together, these findings are largely consistent with Pascoe and Smart Richman's metaanalysis, 4 in that greater perceived discrimination is associated with more negative health behaviors. Given that health behaviors are proposed to mediate the relationship between perceived discrimination and physical health outcomes, additional work testing the full mediation model is needed; longitudinal assessment of this mediation model would make a particularly significant contribution to our understanding of this pathway.
Moderators
Many factors could modify the relationship between perceived discrimination and neurobiological mediators of CVD risk. For example, psychological distress and coping ability are two classes of moderators that have been the focus of prior reviews. 15, 25, 34 While psychological distress and coping ability are likely to modify the relationship between perceived discrimination and neurobiological mediators of CVD, few studies in our review measured these factors. As such, we limit our discussion here to four additional possible moderating factors that were most commonly measured in the studies reviewed here: body composition, racial attribution, SES, and age.
Body composition may modify the relationship between perceived discrimination and neurobiological mediators of CVD risk. Not only is body composition associated with neurobiological mediators of CVD risk, but greater perceived discrimination is also associated with higher BMI, 177 increased weight gain, 178 and incidence of obesity. 179 The mechanisms underlying this relationship are not fully understood. On the one hand, discriminationrelated distress may lead to weight gain through coping-related increases in food consumption. 180, 181 On the other hand, chronic stress can trigger neuroendocrine dysregulation, which can itself lead to increased adiposity. 131, 180 Across studies included in this review, body composition modified the relationship between perceived discrimination and systemic inflammation in several studies. 131, 134, 135 Systemic inflammation and body composition metrics (e.g., BMI) are correlated, 182, 183 suggesting that BMI may confound the relationship between perceived discrimination and systemic inflammation. Thus, future research should elucidate whether body composition moderates, mediates, or confounds the relationship between perceived discrimination and neurobiological mediators of CVD risk.
Another potential moderator is the extent to which an individual attributes discrimination or unfair treatment to his/her race. Across the HPA and immune studies, there were no systematic differences in the relationship between neurobiological mediators and general discrimination versus racial discrimination. However, results from experimental cardiovascular and neural studies suggest that making racial attributions for ambiguous unfair treatment may impact neural or cardiovascular responses. 50, 87, 89, 152 The nature of this effect is not yet clear. In two studies, attributing ambiguous negative treatment to race or racial discrimination was associated with greater BP reactivity among Black women. 50, 87 Conversely, another study found that attributing social rejection to racial discrimination was associated with lower dACC activity and higher rACC activity; 152 because dACC activity is often associated with threat responses, whereas rACC activity is linked with emotion regulation; this finding suggests that making a racial attribution for negative treatment may momentarily reduce feelings of distress and threat and trigger emotion regulation. Thus, making racial attributions may either buffer or exaggerate the effects of perceived discrimination on momentary responses. The impact of attributions may differ from one individual to the next, depending on the availability of coping resources and prior experience with discrimination. Future work should explore the role of making racial attributions for ambiguous unfair treatment; this is especially pertinent, as modern racial discrimination tends to be more ambiguous than overt. 184 SES may also modify the relationship between perceived discrimination and neurobiological mediators of CVD risk. SES could be involved in this relationship at several levels. First, low SES is a chronic stressor related to neurobiological mediators of CVD. 128, 185 Second, low SES is also a potential source of interpersonal discrimination. Third, there is significant overlap between racial and socioeconomic disparities in CVD, as Black Americans are more likely to be of lower SES. Indeed, SES is negatively associated with CVD, such that CVD risk increases as SES decreases. 186, 187 For these reasons, the vast majority of the studies in our review controlled for SES. This statistical adjustment did not seem to attenuate relationships between perceived discrimination and neurobiological mediators, suggesting that these relationships exist beyond the effects of SES. Notably, most studies did not specifically test SES as a moderator of CVD risk. Future work should consider the moderating role of SES, as well as possible interactions between SES and race.
Participant age may also moderate the relationship between perceived discrimination and neurobiological mediators of CVD risk. The reviewed studies included samples ranging from preadolescents to older adults. Findings seemed to be largely consistent from adolescence through midlife. However, samples that included both the youngest 111 and oldest 135 participants reported divergent results from similar studies. Several factors could account for these inconsistencies. For example, biological factors may account for this difference. Among younger individuals, chronic stress-related changes in neurobiological mediators may not have had sufficient time to develop. Among older individuals, other chronic health issues may complicate the measurement of neurobiological mediators, such as systemic inflammation. In addition to biological factors, the meaning of perceived discrimination may vary based on age. Adolescence is typically a critical time for developing a sense of identity, self-esteem, and an understanding of intergroup relations. 188 Among older adults, age is also a source of interpersonal discrimination. Thus, the meaning of perceived discrimination may differ significantly for individuals at the extreme ends of the age spectrum. Overall, however, the association between perceived discrimination and neurobiological mediators of CVD seems to be relatively consistent between adolescence and midlife.
In summary, there are several potential moderators that emerged from the studies discussed in our literature review, including body composition, racial attribution, SES, and age. These moderators add to the existing body of work on psychosocial moderators (e.g., psychosocial distress, coping, and social support) discussed above. Currently, there is not sufficient evidence to fully understand how body composition, racial attribution, SES, and age interact with perceived discrimination to impact brain systems or physiology in the context of CVD. As such, more work is needed to clarify the specific function of these moderators in the relationship between perceived discrimination and neurobiological mediators of CVD, especially in terms of how these moderators might lead to preventive interventions. For example, future work may be able to use these moderators to identify the particular subgroups that would be most promising to target (e.g., Black adults with higher BMI) for interventions.
Discussion
Summary and conceptual model
Our literature review took a multisystem approach to assess potential neurobiological mediators of the relationship between perceived discrimination and CVD risk. Across these systems, there were several relatively consistent relationships. First, the weight of prior evidence would seem to indicate that discriminatory treatment evokes acute cardiovascular reactivity; in addition, history of perceived discrimination is associated with exaggerated cardiovascular reactivity. Second, greater perceived discrimination is linked with flatter diurnal slopes. Third, perceived discrimination is associated with higher levels of systemic inflammation. Finally, brain-body systems linking psychosocial stress and physical health are activated during both general and race-related social exclusion; moreover, greater history of perceived discrimination may be linked with alterations in neural responses to stress in these same brain regions. Taken together, these trends are consistent with the proposition that perceived discrimination affects multiple physiological systems, possibly originating in brain systems for appraisal and regulation of peripheral stress systems.
One goal of the present paper was to assess whether the empirical evidence supports existing models of the relationship between perceived discrimination and physical health. These models largely focus on the effects of perceived discrimination on acute physiological responses and chronic changes in physiological stress systems. Overall, the literature supports the hypothesis that perceived discrimination is associated with acute physiological responses. This support came primarily from studies of cardiovascular reactivity, which showed that both recalled and simulated discrimination evoke cardiovascular responses. The reviewed neural literature provides some explanation for these acute changes, as cardiovascular stress responses are thought to be driven by brain systems involved in appraisal and physiological stress responses. 67, 68 Specifically, regions of the ACC, PFC, and insula seem to be activated during social exclusion, potentially generating and regulating peripheral physiological responses and feelings of psychological distress.
The literature also supports the hypothesis that perceived discrimination is associated with chronic alterations in physiological stress systems. This was evidenced both by exaggerated cardiovascular responses to acute stress and by detrimental HPA axis and immune profiles (i.e., flattened diurnal cortisol slope and heightened systemic inflammation). The neural literature also provides initial insights into these discrimination-related chronic changes. Specifically, one neural study indicated that past perceived discrimination is associated with alterations in brain systems for appraisal and control of peripheral responses to stress. 153 Thus, if greater history of perceived discrimination causes alterations in how these brain systems respond to new stress, it is plausible that altered acute stress responses could lead to enduring changes in cortisol and inflammatory profiles over time. Indeed, Berger and Sarnyai's discrimination and mental health suggests one pathway by which this may occur-frequent or exaggerated peripheral physiological stress responses send afferent signals via viscerosensory pathways "up" to the brain, causing structural and functional alterations in the PFC, ACC, and SN; these alterations could in turn lead to increased vigilance for and sensitivity to future discriminatory experiences and downstream influences over physiology.
In order to integrate these findings with theory and previous models, the work reviewed here has been synthesized into an updated conceptual model. This model aligns with the health neuroscience conceptual approach to examining interrelationships between the brain, psychosocial and biobehavioral factors, and physical health. 189 In our model (Fig. 1) , discrimination or unfair treatment is first processed by interacting brain networks that encompass the individual brain regions discussed in this literature review. These networks function to appraise whether the treatment is threatening and drive affective, behavioral, and physiological responses. These networks likely include three interacting networks-the SN, LN, and DMN. The SN is thought to use afferent signals from homeostatic (peripheral physiological) changes to assign salience or value to events and adjusts future behavioral and physiological responses accordingly; this network includes the aMCC/dACC and the AI. The LN is hypothesized to be responsible for generating core affect and regulating visceromotor responses; this network includes the sgACC, as well as regions of the orbitofrontal cortex (OFC). The DMN is presumably involved in representing prior experience to help generate meaning for current experiences; this network includes the mPFC and the pCC. 69, 70 These interacting networks signal lower order brain systems (e.g., amygdala, hypothalamus, thalamus, and brainstem regions) that trigger downstream physiological stress responses. We recognize that other intrinsic networks and brain systems, including the basal ganglia, may also be especially relevant in this context, but more work is needed at present. Physiological stress responses under the control of visceral brain systems include alterations in the ANS, HPA axis, and immune system. Acute effects of perceived discrimination include increases in cardiovascular reactivity consistent with upregulation of the SNS (e.g., increased BP and HR) and downregulation of the PNS (e.g., decreased HF-HRV). It is unknown whether perceived discrimination elicits acute changes in the HPA axis or immune function. Chronic effects of perceived discrimination include higher nocturnal BP, exaggerated cardiovascular reactivity, changes in HPA axis function (e.g., flattened diurnal cortisol slope), and heightened systemic inflammation. Physiological stress responses typically operate in feedback loops with these same brain systems, providing afferent signals to regulate physiological stress responses and possibly even appraisals. 67 Chronic discrimination may alter these feedback loops and/or alter structure and function in brain systems for appraisal and stress response. In addition to alterations in neurobiological mediators, perceived discrimination may also affect neurobiological mediators of CVD risk via additional psychosocial factors, such as psychological distress and coping ability. These psychosocial factors may act as mediators (e.g., depression) or moderators (e.g., effective social support). Perceived discrimination may also lead to negative health behaviors; some behaviors may be used as coping or stress reduction mechanisms (e.g., tobacco use via brain reward systems), whereas others may be directly affected by stress-related physiological disturbances (e.g., poor sleep via chronobiologic brain systems). These negative health behaviors can contribute to dysregulation of physiological stress systems. Taken together, these acute and chronic alterations in neurobiological mediators confer greater risk for CVD pathophysiology.
This model may vary by race and distal contextual influences, including social, cultural, and environmental influences. One possibility is that perceived discrimination exerts a greater impact on CVD risk among Black individuals through these neurobiological pathways, plausibly accounting for some of the racial disparities in CVD at the epidemiological level. However, many of the reviewed studies found equally adverse effects of perceived discrimination on neurobiological mediators across racial groups. Thus, the lack of race differences raises the additional possibility that experiences of discrimination have a similarly negative impact across racial groups. Indeed, individuals experience discrimination for a wide range of reasons that are unrelated to race (e.g., gender, sexual orientation, weight, etc.). Hence, such experiences, regardless of reason, can engage the same neurobiological pathways to confer risk.
How, then, are we to interpret the role of perceived discrimination in racial disparities in CVD? One approach to addressing this question is to consider differences in lifetime discriminatory burden across racial groups. Black individuals consistently report more frequent and severe racial discrimination compared with White individuals, and these experiences begin earlier in life. Consequently, the biggest difference in our model between racial groups may not be in the individual pathways themselves, but in how long and how frequently exposure to discrimination occurs and, thus, how frequently the mediating risk pathways are activated. The HPA axis literature provides an illustrative example. In the HPA axis studies reviewed herein, several studies reported no differences in the association between discrimination and diurnal cortisol slopes between White and Black individuals. On the surface, these findings do not seem to lend strong support for the idea that HPA axis function fully accounts for racial disparities in CVD. However, when interpreting our model as a whole, we must consider the fact that Black individuals report experiencing more frequent and severe discrimination across their lifetime in a manner that may not be captured by cross-sectional studies. As such, HPA activity may be a plausible mediator if there is a higher lifetime discriminatory burden among Black individuals and a correspondingly higher lifetime HPA load compared with other racial groups. However, there is not sufficient evidence to support this scenario, as we lack appropriate longitudinal and multilevel studies. This lack of evidence prevents us from making reliable conclusions about race differences with respect to our proposed model. As such, future work testing how this model might vary across racial groups within a given context or time period could strengthen our understanding of how perceived discrimination affects racial disparities in CVD.
Limitations and future directions
There are a number of limitations and methodological issues in the literature on discrimination and health that should be noted. First, discrimination measurement continues to be highly heterogeneous across studies. Most studies measure racial discrimination, but several measured general discrimination; although general measures are typically accompanied by a racial attribution question, attributions are not always included in statistical analyses. Discrimination measures are also heterogeneous in that some measure frequency of discrimination experiences, whereas others assess the severity or emotional impact of those experiences. Although we grouped these measures together for purposes of our review, future work should assess whether different facets of discrimination are differentially associated with neurobiological mediators of CVD.
There are also a number of sample-related considerations. In particular, our conclusions regarding race differences are limited by the racial homogeneity of most samples. The vast majority of the literature is limited to Black and White samples, with very little research on other racial/ethnic minority groups. Future work should include more racially and ethnically diverse samples to better understand race differences in the proposed conceptual model. Moreover, future studies could also benefit by breaking broad racial groups into more specific subgroups that may have different experiences with discrimination (e.g., dividing Latino participants into immigrant and nonimmigrant subgroups). In addition to race issues, there were notable distinctions between samples in the cardiovascular reactivity and neural studies compared with the immune studies. The cardiovascular and neural studies tended to be smaller experimental studies with younger participants (e.g., undergraduates), whereas the immune studies tended to be larger epidemiological studies with midlife adult participants. Thus, the different components of this conceptual model should be tested in larger samples across broader age ranges.
Finally, it is notable that many of the reviewed studies did not control for other chronic stressors.
Although most immune and HPA studies controlled for at least one measure of SES, many cardiovascular and neural studies did not. Given that other chronic stressors are consistently linked with neurobiological mediators of CVD, it is difficult to parse out the unique influence of perceived discrimination from other stressors. It will be essential for future work to examine whether the impact of perceived discrimination is distinct from other chronic stressors.
Beyond remedying these methodological issues, there are several additional future research directions that could clarify and contribute to the existing literature on perceived discrimination and neurobiological mediators of CVD risk.
Clarification of pathways. First, several pathways in the proposed conceptual model depicted in Figure 1 require further research. In particular, future work should assess the acute effects of perceived discrimination on immune and HPA axis function. Laboratory reactivity studies show that exposure to acute stress evokes increases in inflammatory markers, such as IL-6. 190 Thus, future work should assess whether perceived discrimination can also evoke these acute changes in circulating inflammatory markers and whether history of perceived discrimination is associated with exaggerated acute inflammatory responses. Acute alterations in HPA axis function are more difficult to measure; acute stress does evoke increases in peripheral cortisol; however, these responses are not always reliable. 104 Nonetheless, future studies could explore the possibility that perceived discrimination or acute discriminatory events are associated with acute alterations in cortisol responses or short-term variations in diurnal cortisol patterns.
Future work should also clarify if perceived discrimination has other chronic effects on cardiovascular measures beyond nocturnal BP and exaggerated cardiovascular reactivity. For example, perceived discrimination may be associated with endothelial dysfunction. Two existing studies assess this possibility; 191, 192 however, these studies could not be meaningfully reviewed here, due to significant variations in study design (e.g., cross-sectional versus acute reactivity) and endothelial dysfunction measures (E-selectin versus flow-mediated dilation).
Greater exploration of brain systems. Future work could also clarify brain systems implicated in appraising and responding to perceived discrimination. In particular, additional neuroimaging research would increase our understanding of the brain systems involved in appraising and processing potentially discriminatory treatment. This line of research has several possible directions. First, future work could better characterize patterns of neural activity that are specific to processing racial discrimination; such evidence could elucidate the extent to which these patterns overlap with processing of social exclusion. While the existing neuroimaging work on social exclusion is a promising first step, social exclusion is just one facet of perceived discrimination. There is a clear need for novel neuroimaging work specifically focused on experiences and perceptions of discrimination and the brain systems engaged by them. Second, this work could assess whether individual differences in neural processing of discrimination are associated with neurobiological mediators of CVD risk. Third, future studies could help determine whether chronic exposure to perceived discrimination leads to functional or structural alterations in brain systems involved in processing perceived discrimination and whether these alterations lead to maladaptive peripheral physiological responses over time. These future directions could be assessed through multimodal and longitudinal neuroimaging approaches that are integrated with epidemiological and health psychology approaches.
Multisystem approach. The vast majority of the reviewed studies assessed the relationship between perceived discrimination and a single neurobiological mediator or system. However, these stress systems do not function in isolation, but are functionally linked with each other and regulated by the central nervous system. Thus, measuring a single mediator or system does not provide a comprehensive picture of how perceived discrimination impacts stress physiology. For this reason, future research should strive to take a multisystem approach that characterizes patterns of physiological responses across individuals, as well as individual differences in patterns that might ultimately confer greater risk for CVD.
Increased focus on the role of protective factors.
One of the aims of our review was to assess potential moderators of the relationship between perceived discrimination and neurobiological mediators of CVD risk. However, only four studies assessed factors that protect or buffer an individual from the effects of perceived discrimination. Thus, it was not feasible yet to fully address this aim. However, in the future, it will be important to understand the extent to which repeated exposure to discrimination depletes the capacity to respond to additional stressors that are often correlated with discriminatory experiences and the extent to which discrimination undermines the ability to cope effectively in multiple life domains.
Formal mediation testing with longitudinal study designs. Finally, future research must connect the findings from our review to longitudinally assessed CVD outcomes. The scope of our review was limited to relationships between perceived discrimination and established neurobiological mediators of CVD risk. Moreover, the vast majority of these studies were cross-sectional and could not assess directional relationships. Notably, the few existing longitudinal studies did find that perceived discrimination prospectively predicted systemic inflammation and diurnal cortisol slope. 113, 131, 136 In the future, longitudinal studies measuring CVD outcomes are needed; this would make it possible to test a formal mediation model whereby perceived discrimination predicts neurobiological mediators, which in turn predict CVD risk.
Conclusion
Existing literature indicates that perceived discrimination is related to many neurobiological mediators of CVD risk across different physiological stress systems, including the ANS, HPA axis, and immune system. Moreover, initial neuroimaging evidence indicates that brain systems involved in appraisal and regulating peripheral stress responses may be activated or altered in response to social exclusion and discrimination. These findings were integrated into a preliminary conceptual model describing multidirectional pathways linking perceived discrimination with CVD risk. Future work in this field can clarify different pathways in this conceptual model and factors that moderate each pathway.
